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The Western Cape province of South Africa has a high
incidence of tuberculosis (TB); in 2000 and 2001 the incidence
within the Cape Town metropole region was 562 and 581/100
000 population, respectively.
1
Children under 15 years of age
form between 15% and 20% of this TB burden. Further, during
the 2001 anonymous national HIV survey of women attending
public antenatal clinics 8.6% (95% confidence interval (CI): 5.6 -
11.6%) of pregnant women in the Western Cape were HIV-
infected.
2
During 1998 and 1999 the antenatal HIV prevalence
rates were 5.2% and 7.1%, respectively. This coincidence of
high TB incidence rates and increasing HIV infection rates in
mothers has meant that considerable numbers of young
children with TB are co-infected with HIV.
Directly observed therapy, short-course (DOTS) is the
preferred manner to manage TB treatment in the community.
3
Severely ill patients or those who have socio-economic
problems may, however, still require hospitalisation. In
children, problems may be compounded by the caregivers’
inability to take them to a clinic or community DOTS supporter
because of infirmity, old age or fear of losing their
employment.  Children are admitted to Brooklyn Hospital for
Chest Diseases (BHCD) once they have been evaluated at a
referral hospital. BHCD accommodates 60 children, 40 aged up
to 5 years and 20 aged from 6 to 14 years. A previous
descriptive study
4
documented the clinical features of children
with TB admitted to BHCD during 1998 and 1999; 25% of 150
were found to be HIV-infected. An increased mortality rate and
a higher incidence of multidrug resistance was found among
the HIV-infected children. This study continues the documen-
tation of the clinical features and outcome of TB among
children admitted to BHCD during 2000 and 2001.
Materials and methods
This was a retrospective, descriptive study of all children
under 15 years of age admitted to BHCD from 1 January 2000
to 31 December 2001.  Demographic data and clinical details of
all children were routinely recorded in a register that formed
the basis of this review. Missing information was retrieved
from clinical folders and chest radiographs. Information
regarding age at TB diagnosis, sex, clinical and radiological
findings, the results of testing for HIV infection, Mantoux
tuberculin skin testing (TST) and results of cultures for
Mycobacterium tuberculosis and drug susceptibility were
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Background. The Western Cape has a high incidence of
tuberculosis (TB) and a rising prevalence of HIV infection.
Children form 15 - 20% of this TB burden. 
Objective. To document the clinical features and outcome of TB
among children admitted to a regional TB hospital. 
Method. A retrospective, descriptive study was undertaken of
children under 15 years of age admitted to Brooklyn Hospital
for Chest Diseases from January 2000 to December 2001.
Demographic and clinical details of children were recorded
routinely in a register that formed the basis of this review.
Results. Two hundred and thirty-eight of the 250 children
admitted had TB, of whom 120 (50.4%) were boys. The median
age was 25 months. Reasons for admission were disease
severity in 99 cases, social reasons in 36, and a combination in
103. Adult source cases were identified in 138 instances; 9 had
drug-resistant TB, 31 drug-susceptible TB and in 98 cases
susceptibility was unknown. TB was confirmed by culture in
119 children. Of 79 in whom susceptibility testing was done, 10
had isoniazid-resistant TB and 8 multidrug-resistant TB. HIV
serology was positive in 43 of 138 children tested (31%).
Previous antituberculosis treatment, severe malnutrition and
weight under the 3rd percentile for age, a negative Mantoux
test, and mortality were significantly more common in the HIV-
infected children. Twenty-two of 41 previously negative
Mantoux tests (< 5 mm induration) were positive on retesting.
Conclusions. HIV infection is common in children with TB and
malnutrition, and mortality in this group is high.  Repeat
Mantoux tests may show an increased number of positive
results.
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collected on data capture forms. Details of the history included
contact with an adult TB source case, the relationship between
the source case and the child, drug susceptibility results of the
source case’s isolates, previous TB treatment and the child’s
presenting symptoms. 
The children were divided into nutritional categories
according to the Wellcome classification of weight for age.
Nosocomial infections and drug adverse events were recorded.   
Mantoux TST with 2 units RT/23 tuberculin (Statens
Seruminstitut, Copenhagen, Denmark) was noted as
significantly positive in HIV-uninfected children if an
induration of ≥ 15 mm was measured.
5
In HIV-infected
children an induration of ≥ 5 mm was regarded as significant.
5
HIV serology was evaluated when clinical findings indicated
HIV disease or the mother was known to be HIV-infected. HIV
infection was confirmed by 2 enzyme-linked immunosorbent
assays (ELISAs) using kits from different manufacturers, and
by polymerase chain reaction (PCR) in children < 15 months of
age. 
Cultures for M. tuberculosis and drug susceptibility test
results were obtained where available. Drug susceptibility
testing was initially only for isoniazid (INH) and rifampicin
(RMP) as previously described.
4
A diagnosis of confirmed TB was made in the presence of a
culture of M. tuberculosis from any source, or if sputum smear
microscopy or histological assessment was positive for acid-
fast bacilli. A diagnosis of probable TB was made in the
presence of 2 or more of the following: (i) a positive TST; (ii) a
chest radiograph showing hilar or paratracheal adenopathy;
(iii) recent (within 12 months) close household contact with a
sputum smear-positive pulmonary TB (PTB) case; and (iv) in
the case of suspected tuberculous meningitis (TBM), a
computed tomography (CT) scan showing hydrocephalus and
basal enhancement. Children with a positive TST, but without
any clinical or radiological signs were regarded as having TB
infection only.
Uncomplicated primary TB (mediastinal adenopathy with
limited involvement of lung parenchyma) was managed with
INH, RMP and pyrazinamide (PZA) for 2 months followed by
INH and RMP for 4 months. In the presence of pulmonary
cavitation or dissemination to multiple organs excluding the
brain, ethambutol (EMB) was added during the initial 2
months of treatment. Children with TBM and miliary TB
received 6 months’ treatment with INH, RMP, PZA and
ethionamide.
6
Children with known drug-resistant TB or in
contact with adults with known drug-resistant TB were treated
taking into account the drug susceptibility test of the child or
adult source case. Treatment in HIV-infected children was often
extended to 9 months in the presence of more extensive
disease. 
Categorical data were analysed using the chi-square test with
Yates’ correction and Fisher's exact test where appropriate.
Statistical analysis was done using EpiInfo version 6.03.
The study was approved by the Institutional Review Board
of the Faculty of Health Sciences of Stellenbosch University.
Results
From January 2000 to December 2001, 250 children were
admitted to BHCD. Twelve children were excluded from
analyses; 2 were older than 15 years and 10 were considered
not to have TB. The median age of the remaining 238 children,
of whom 120 (50.4%) were boys, was 25 months (range 1 - 171
months) at diagnosis. 
HIV serology was done in 138 of 238 children (58%), and was
positive in 43 (31%). The children were divided into an HIV-
uninfected group A (N = 95), an HIV-infected group B (N = 43)
and those not evaluated for HIV, group C (N = 100). The
median age (range) in months was 21 (1 - 171 months), 29 
(1 - 137 months) and 29 (1 - 168 months) for children in groups
A - C, respectively. 
The reasons for admission to BHCD were severity of disease
in 99 children (42%), social reasons such as the caregiver’s
inability to care for the child, failure to comply with treatment
or admission of the mother to BHCD in 36 children (15%), and
both severity of disease and social reasons in 103 children
(43%). Tertiary hospital referrals accounted for 114 admissions
(48%), secondary hospitals for 91 admissions (38%) and
primary care facilities for 33 admissions (14%). Of these, 69, 31
and 4 children from the respective referral levels presented
with TBM.
Contact with adult PTB was documented in 56 (59%), 27
(63%) and 55 (55%) children in groups A, B and C, respectively.
Of these 138 children, 104 (76%) had 1, 28 (20%) had 2, and 6
(4%) had 3 or more known adult source cases; the mother in 50
(36%), the father in 26 (19%), an uncle and/or aunt in 39 (28%),
a grandparent(s) in 17 (12%), another household member in 29
(21%), and a neighbour in 5 (4%).
TB was confirmed by culture in 119 children (50%) and
microscopy for acid-fast bacilli (AFB) was positive in a further
5 (2%). The culture source was gastric aspirate in 79 (33%),
sputum in 32 (13%), cerebrospinal fluid in 17 (7%), lymph node
biopsy in 5 (2%) and bronchial aspirate in 4 (2%). AFB only
were found in 1 lymph node biopsy, 1 sputum and 3 gastric
aspirates. TB was confirmed in 59 (62%), 23 (53%) and 42 (42%)
children in groups A, B and C, respectively.
Nine of 138 children (7%) with known source cases were in
contact with adults with drug-resistant TB, 8 of whom had
multidrug-resistant (MDR) TB (i.e. resistance to INH and RMP,
with or without resistance to other drugs). Cultures for M.
tuberculosis were obtained from 4 of these children, of whom 3
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had MDR and 1 had INH-resistant TB. The drug susceptibility
patterns were identical to those of the adult source. Drug
susceptibility test results of isolates from a further 31 (22%)
children’s adult source cases were known and were fully
susceptible. 
Drug susceptibility tests in 93 of 119 children (78%) with
positive cultures confirmed resistance in 18 children (19%); 10
had INH resistance only and 8 had MDR TB. Only 1 HIV-
infected child had drug-resistant (MDR) TB. In 8 children with
confirmed resistance (3 MDR) the HIV status was unknown
and in 9 (4 MDR) the children were HIV-uninfected. 
A history of previous antituberculosis treatment was
obtained from 52 children (22%); 18 (19%) in group A, 16 (37%)
in group B (B and A odds ratio (OR) 2.53, 95% CI: 1.05 - 6.11)
and 18 (18%) in group C (B and C OR 2.70, 95% CI: 1.12 - 6.50).
Of these 52 cases, 8 (15%) had confirmed drug resistance (2
INH resistance and 6 MDR) and a further 2 had adult MDR
source cases. Only 11 (21%) had been adherent to previous
treatment, 28 (54%) were not adherent and in 13 (25%)
adherence was not known.
Weight for age < 3rd percentile was significantly more
frequent in group B children (33/43; 77%) than in groups A
(53/95, 56%) (OR 2.62, 95% CI: 1.08 - 6.43) or C (40/100, 40%)
(OR 4.95, 95% CI: 2.06 - 12.15). Group A also had significantly
more underweight children than group C (OR 1.89, 95% CI:
1.03 - 3.49). Severe malnutrition (marasmus and/or
kwashiorkor) was significantly more common in group B
(14/43) than in groups A (15/95, OR 2.57, 95% CI: 1.02 - 6.50)
and C (8/100, OR  5.55, 95% CI: 1.93 - 16.28). There was no
significant difference between groups A and C. Nutritional
status improved in all groups during hospitalisation, but the
HIV-infected children’s weight-for-age percentiles remained the
lowest. At the time of discharge, 28 (29%), 20 (47%) and 20
(20%) of the children in groups A, B and C still had a weight
for age < 3rd percentile.
Table I summarises the site of TB. Extrapulmonary
tuberculosis (EPTB) was evenly distributed among the groups.
Both PTB and EPTB were found in 58 (61%), 30 (69%) and 51
(51%) children in groups A, B and C respectively. The
remaining 2, 3 and 2 children in the respective groups were
diagnosed with TB infection only. 
The intrathoracic manifestations of TB on chest radiograph
are summarised in Table I. Only 3 group B children (7%) had a
normal chest radiograph compared with 14 (15%) and 28 (28%)
Table I. Site of TB disease, Mantoux tuberculin test and chest radiograph results
HIV infection status Odds ratio (95% 
Not determined CI) group A
Uninfected (group A) Infected (group B) (group C) compared with 
N = 95 (%) N = 43 (%) N = 100 (%) group B*
Pulmonary TB 80 (84) 35 (81) 69 (69) NS
Extrapulmonary TB (total) 71 (74) 35 (81) 80 (80) NS
TB meningitis 31 (33) 11 (26) 62 (62) NS
Miliary TB 22 (23) 13 (30) 13 (13) NS
Pleural effusion 20 (21) 13 (30) 9 (9) NS
Abdominal TB 13 (14) 7 (16) 3 (3) NS
Pericardial effusion 2 (2) 0 4 (4) NS
Peripheral lymph nodes 5 (5) 2 (5) 2 (2) NS
Osteo-articular TB 5 (5) 0 1 (1) NS
Mantoux test (done and read) 84 (88) 40 (93) 90 (90) NS
Induration (in mm) 
≥ 15 55 (65) 16 (40) 61 (68) 2.32 (1.04 - 5.21)
≥ 5 - 14 10 (11) 6 (15) 18 (20)
Chest radiograph features
Mediastinal lympadenopathy 38 (40) 18 (42) 36 (36) NS
Lobar/segmental opacification 39 (41) 25 (58) 35 (35) NS
Bronchopneumonic opacification 6 (6) 4 (9) 4 (4) NS
Miliary picture 22 (23) 13 (30) 13 (13) NS
Pleural effusion 20 (21) 13 (30) 9 (9) NS
Cavities or pneumatoceles 21 (22) 9 (21) 6 (6) NS
Ghon focus 0 0 2 (2) NS
Calcifications 2 (2) 0 4 (4) NS
Normal chest radiograph 14 (15) † 3 (7) † 28 (28)† NS
* Group C was not compared, as HIV status was not known.
† TB meningitis in 11, 0 and 22 children and infection only in 2, 2 and 3 children in groups A, B and C, respectively.
NS = not significant. 
602-606 pgs SPOT  8/1/05  1:02 PM  Page 604
ORIGINAL ARTICLES
605
August 2005, Vol. 95, No. 8  SAMJ
in groups A and C (OR groups A and B not significant).
Mediastinal lymphadenopathy was equally frequent among the
3 groups. The final Mantoux TST results are given in Table I.
TST was repeated in 41 of 75 children after a month or more
when the initial TST showed < 5 mm induration. Of these, 27
(66%) showed a greater response and 22 (54%) developed an
induration of ≥ 15 mm. Eleven of 21 (52%), 4 of 6 (67%) and 11
of 14 (79%) children from groups A, B and C, respectively, had
a follow-up Mantoux induration of ≥ 10 mm.  If ≥ 15 mm
induration is used as cut-off for a significantly positive
Mantoux TST in the HIV-uninfected group and ≥ 5 mm
induration for HIV-infected children, there was no significant
difference in positive TSTs in the final results (OR = 1.55, 95%
CI: 0.67 - 3.59). 
While in hospital, jaundice as an adverse event developed in
7 children and drug rash occurred in 4. Drug adverse events
did not differ significantly between groups. Nosocomial sepsis,
bacterial meningitis or pneumonia were diagnosed in 2 (2%), 5
(12%) and 3 (3%) children in groups A, B and C, with a trend to
more nosocomial infections in group B than A (OR 6.12, 95%
CI: 0.99 - 47.8). During the review period a chickenpox
outbreak occurred; 62 children were affected, with a similar
percentage in each group.
The length of stay in BHCD was a median of 5 months in all
groups, with a range from 1 to 12 months, 1 to 20 months and 1
to 15 months in groups A - C. The median treatment duration
was 6 months (range 2 - 18 months in both) for groups A and
C, but 9 months (range 1 - 24 months) for group B. The
outcome at the end of hospitalisation is presented in Table II. A
significantly higher percentage of group B children died than
in either groups A or C. The cause of death was not always
clear, but TBM stage III was present in 5 and miliary TB in 4.
Of the 6 deaths among the HIV-infected children, only 1 was
directly related to TB, 4 were HIV-related and 1 died of an
unknown cause.
Discussion
This study documents the continued impact of HIV infection
on the occurrence of childhood TB in our region. During a
previous survey of paediatric admissions to BHCD4 a very
similar proportion of children were evaluated for HIV
infection; 57% in the previous review and 58% during this
survey. Despite measures to prevent mother-to-child HIV
transmission in our region a higher proportion, although not
significant, of children admitted to BHCD and evaluated for
HIV infection during this survey (31%) were HIV-infected
compared with the previous survey (25%) (OR  1.43 (0.83,
2.49)).  In keeping with our previous survey,
4
and the
experience of others in Africa,
7
HIV-infected children did not
present with more EPTB than HIV-uninfected children.  It is
also noteworthy that all but 3 (7%) of the HIV-infected children
had intrathoracic manifestations of disease in contrast to HIV-
uninfected children (15%) and those not evaluated (28%). 
A higher mortality rate was again experienced by the HIV-
infected children and was the consequence of HIV infection
and its complications rather than TB despite the children
receiving cotrimoxazole prophylaxis. Cotrimoxazole
prophylaxis has reduced the mortality rate in adults with TB.
8





are well known; it is therefore not surprising that at TB
diagnosis more children in group B than in groups A or C had
a weight for age < 3rd percentile and suffered from both
kwashiorkor and marasmus. In the absence of antiretroviral
therapy and despite supervised antituberculosis treatment,
adequate nutrition and supplements provided in hospital,
many HIV-infected children also failed to gain weight
satisfactorily. 
It was distressing that 52 children (22%) had been treated
previously for TB; this was particularly likely to be the case in
the HIV-infected children, and treatment instructions were
followed in only a minority of these cases. It has been forcibly
Table II. Outcome at the end of hospitalisation
Odds ratio 
HIV-uninfected HIV-infected HIV not determined (95% CI)*
(group A) (group B) (group C) group A v.
HIV infection status N = 95 (%) N = 43 (%) N = 100 (%) group B
Cured † 44 (46) 9 (21) 33 (33) 3.26 (1.32 - 8.24)
Cured with remaining pathology ‡ 23 (24) 6 (14) 27 (27) NS
Transferred to another hospital 8 (8) 4 (9) 6 (6) NS
Discharged to complete treatment
at a community clinic 16 (17) 16 (37) 29 (29) 0.34 (0.14 - 0.84)
Died 2 (2) 6 (14) 5 (5) 0.13 (0.02 - 0.78)
Absconded 2 (2) 2 (5) 0 NS
* No significant differences were found comparing groups A or B with group C. 
† Cured – culture-negative, clinical findings normal with radiological resolution.  
‡ Remaining pathology – culture-negative but clinical or radiological abnormalities persist.
NS = not significant.
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pointed out that such failures should be regarded as failures of
the system and not necessarily ascribed to patient negligence,
or in the case of children, to negligence of caregivers.
11
Problems associated with compliance with treatment
instructions with regard to childhood TB have been noted by
several groups.
12,13
Distance from clinics, lack of help with the
supervision of other children during clinic visits and fear of
losing employment, have been identified as problems.
Childhood TB is also not a priority for TB services in high-
incidence communities, yet ironically it is in precisely these
areas that large numbers of children needing treatment will be
found.
14
Drug resistance was confirmed in 18 of the 93 children (19%)
for whom drug susceptibility test results were available.
During the previous survey 20 isolates (25%) from 79 children
were drug resistant.
4
The importance of a history of possible
contact with a drug-resistant index case is again illustrated. It is
distressing that a history of previous TB treatment and failure
of compliance was associated with drug resistance in some
patients. Drug resistance is usually considered to be new
(primary) resistance in childhood, but several of our patients
could be classified as having previously treated (acquired)
drug resistance. 
In developing countries with limited resources the TST is a
mainstay of the diagnosis of childhood TB. A Mantoux TST
gave an induration of ≥ 15 mm in approximately two-thirds of
groups A and C children, but only 40% of the group B children.
Nonetheless taking into account those HIV-infected children
who reacted with ≥ 5 mm induration, more than 50% of the
HIV-infected children did have a significantly positive result.
We would also draw attention to the potential value of
repeating the TST in those children in whom TB is strongly
suspected. Improved nutrition and a booster response may
contribute to improved results on retesting.
The high proportion of children with TBM admitted to
BHCD is a reflection of the intensity of the TB epidemic in the
Western Cape. In the period 1985 - 1987, before the advent of
the HIV epidemic, an annual risk of TB infection for the
Western Cape of 2 - 3% was calculated and the incidence of
TBM in children 0 - 4 years of age was 24.3/100 000
population.
15
Our data indicate that the situation has not
improved in the intervening 15 years. Our experience amply
illustrates the pernicious interaction of the concurrent HIV and
TB epidemics and their influence on children.  It is hoped that
the availability of antiretroviral agents will contribute to the
better management of both these infections.
The authors thank Dr S Moeti, Medical Superintendent of
Brooklyn Hospital for Chest Diseases for permission to publish,
and the Nestlé Community Paediatric Fund for financial support.
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